Directed new share issue in Medivir AB (SE) — SEK 155 million

Carnegie acted as global co-ordinator and joint bookrunner in the directed new share issue of 3,968,841 new Class B shares at a price of SEK 39 per share. Medivir is a research-based pharmaceutical company with a focus on oncology. February 2018.